NCT02166593View on ClinicalTrials.gov

Clinical Trial to Evaluate the Efficacy and Safety of Pravafenix Cap to Verify the Superiority Than Atorvastatin

PHASE3CompletedINTERVENTIONAL

Enrollment

302

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions

Combined Dyslipidemia

Interventions

DRUG

Pravastatin40mg/Fenofibrate160mg

Pravafenix(Pravastatin40mg/Fenofibrate160mg)

DRUG

Atorvastatin Sodium 10mg

Lipitor 10mg(Atorvastatin Sodium)

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors

lead

Yooyoung Pharmaceutical Co., Ltd.

INDUSTRY

NCT02166593 - Clinical Trial to Evaluate the Efficacy and Safety of Pravafenix Cap to Verify the Superiority Than Atorvastatin | Biotech Hunter | Biotech Hunter